Clearbridge Health completes placement of 309.5 million shares

The company’s total issued shares have increased to 2.17 billion shares.

Clearbridge Health Limited has completed its placement of 309.5 million new ordinary shares at $0.0031 per share, as announced on 19 December 2024 and 9 January 2025.

Following the placement, the company’s total issued shares have increased from 1.86 billion to 2.17 billion shares. The new shares will be listed and quoted on the SGX-ST’s Catalist board starting 14 January 2025, with trading set to begin at 9:00 a.m.

The new shares will rank pari passu with existing shares but will not entitle holders to any dividends or distributions declared before the allotment date.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia